Adverse Event Reporting From Malaria Mass Drug Administration Rounds Conducted in Southern Province, Zambia

This poster demonstrates that the use of DHAp for malaria treatment was generally safe and well tolerated. A total of 687 adverse events (AEs) were reported (0.13% of participants, 0.24% of treatments). Four AEs were initially reported as serious adverse events, though three were later identified as not related to drug ingestion.

Publication date: November 2016

Adverse Event Reporting From Malaria Mass Drug Administration Rounds Conducted in Southern Province, Zambia

2.8 MB PDF

Hard copies are not available.

View Resource